Immuneering Corp

IMRX · Nasdaq · SIC 2834: Pharmaceutical Preparations
77
SEC Filings

Business Summary

EX-23.1 3 imrx-2021231x10kxexx231.htm EX-23.1 Document Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the Registration Statements (Nos. 333-289589 and 333-289997) on Form S-3 and Registration Statements (Nos. 333-258416 and 333-286973) on Form S-8 of Immuneering Corporation of our report dated March6, 2026, relating to the consolidated financial statements of Immuneering Corporation and its subsidiaries, appearing in this Annual Report on...

Next Earnings

Q2 FY2026 — expected 2026-09-17

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-062025-12-310001790340-26-000042EDGAR100K words
2025-03-202024-12-310001790340-25-000042EDGAR
2024-03-012023-12-310001790340-24-000024EDGAR
2023-03-062022-12-310001558370-23-002905EDGAR
2022-03-102021-12-310001558370-22-003208EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-300001790340-25-000135EDGAR70K words
2025-08-132025-06-300001790340-25-000104EDGAR
2025-05-052025-03-310001790340-25-000061EDGAR
2024-11-132024-09-300001790340-24-000080EDGAR
2024-08-062024-06-300001790340-24-000066EDGAR
2024-05-072024-03-310001790340-24-000056EDGAR
2023-11-092023-09-300001790340-23-000056EDGAR
2023-08-032023-06-300001790340-23-000048EDGAR
2023-05-042023-03-310001790340-23-000023EDGAR
2022-11-102022-09-300001558370-22-017304EDGAR
2022-08-102022-06-300001558370-22-013063EDGAR
2022-05-102022-03-310001558370-22-007953EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-060001790340-26-000040EDGAR3K words
2026-01-070001790340-26-000006EDGAR
2025-11-120001790340-25-000133EDGAR
2025-09-250001104659-25-093436EDGAR
2025-09-240001104659-25-092957EDGAR
2025-08-250001104659-25-081995EDGAR
2025-08-130001790340-25-000102EDGAR
2025-06-170001790340-25-000077EDGAR
2025-06-160001790340-25-000063EDGAR
2025-05-050001790340-25-000059EDGAR

77 total filings indexed. 50 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001790340
TickerIMRX
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: b52a32b0e00f208ada10be98b045370833ee6c2deb65fc41b524e1170e3a7157
parent: 35cc711988f132413cdea9a41988358429a44a4a2a4f5487446a8b402af0a872
content hash: 86ed898806ea1e75a7f5b40fce8fab3c8940a1edb40de3d0493ad4e361f36031
signed: 2026-04-13T04:45:40.801Z
sources: 17 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf